Search for: "ALLERGAN USA"
Results 1 - 20
of 91
Sorted by Relevance
|
Sort by Date
15 Apr 2019, 6:09 am
Teva Pharmaceuticals USA Inc.: Allergan & SRMT Cert Petition Questions presented: Whether the Federal Circuit erred in this case, as it did in Acorda Therapeutics, Inc. v. [read post]
26 Sep 2019, 11:53 am
Allergan USA, Inc. v. [read post]
12 Sep 2019, 2:44 pm
’s (“AbbVie”) acquisition of Allergan plc (“Allergan”). [read post]
17 Oct 2017, 8:15 am
Bryson of the United States Federal District Court for the Eastern District of Texas found that Allergan's RESTASIS® patents were infringed by Teva Pharmaceuticals USA, but that Teva had demonstrated invalidity of those patents by clear and convincing evidence... [read post]
23 Jul 2018, 2:38 pm
Mylan Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., AKORN, Inc. [read post]
16 Feb 2020, 9:51 pm
Allergan USA, Inc. v. [read post]
4 Mar 2020, 9:59 pm
Allergan USA, Inc. v. [read post]
13 Jun 2010, 9:35 pm
Paddock Laboratories Inc. 1:10-cv-00501; filed June 9, 2010 in the District Court of Delaware • Plaintiffs: Allergan Inc.; Allergan USA Inc.; Allergan Sales LLC; Endo Pharmaceuticals Solutions Inc.; Supernus Pharmaceuticals Inc. [read post]
17 Oct 2017, 8:15 am
Bryson of the United States Federal District Court for the Eastern District of Texas found that Allergan's RESTASIS® patents were infringed by Teva Pharmaceuticals USA, but that Teva had demonstrated invalidity of those patents by clear and convincing evidence... [read post]
16 Oct 2017, 12:36 pm
Teva Pharmaceuticals USA Inc. [read post]
6 May 2013, 4:33 pm
USA Inc.), 'there is no requirement in patent law that the person of ordinary skill be motivated to develop the claimed invention based on a rationale that forms the basis for FDA approval'. [read post]
4 Aug 2015, 11:27 am
Allergan’s inventors surprisingly determinedthat the opposite was true, namely, that 200 ppmBAK enhanced the permeability of bimatoprost. [read post]
20 Jul 2018, 11:44 pm
TevaPharmaceuticals USA, Inc., and Akorn, Inc. [read post]
19 Oct 2017, 10:29 am
Teva Pharmaceuticals USA, Inc. et al, Case No. 2:15-cv-1455-WCB (EDTX October 16, 2017 Order), a Federal District Court recently invalidated several patents covering Allergan’s dry-eye drug Restasis. [read post]
19 Oct 2017, 10:29 am
Teva Pharmaceuticals USA, Inc. et al, Case No. 2:15-cv-1455-WCB (EDTX October 16, 2017 Order), a Federal District Court recently invalidated several patents covering Allergan’s dry-eye drug Restasis. [read post]
19 Aug 2013, 3:50 pm
This two part post is about the recently revoked patents owned by Allergan Inc (USA). [read post]
3 Apr 2017, 9:59 pm
Allergan, Inc. [read post]
17 Oct 2016, 7:49 pm
Allergan and Forest Labs., Case No. 16-cv-09 (E.D.Tex. 2016) (SEALED USA Complaint). [read post]
8 Aug 2018, 11:15 pm
However, Allergan’s insurance policy may never pay out – in late July, the Court of Appeals for the Federal Circuit rejected the applicability of tribal sovereign immunity to IPR. [read post]
16 Jan 2021, 8:38 am
By Memorandum Opinion entered in Allergan USA, Inc. et al. v. [read post]
